Breaking News Instant updates and real-time market news.

2020-03-17 07:58:39 FB Facebook $145.83 / -24.83 (-14.55%) 07:58 03/17/20 03/17 07:58 03/17/20 07:58	Facebook added to Securities Investment Committee's Best Ideas List at Wedbush Wedbush analyst Michael Pachter added the shares of Facebook to the Wedbush Securities Investment Committee's Best Ideas List. The analyst expects Facebook to continue its rapid growth overseas and to increase monetization of under-penetrated Instagram, WhatsApp, and Messenger. Pachter has an Outperform rating and a $250 price target on the shares.	17 Mar 17 Mar 25 Mar 20 Apr 14 Sep
FB Facebook $145.83 / -24.83 (-14.55%) 03/11/20 Mizuho Mizuho says own Internet stocks that benefit from travel restrictions 03/06/20 Needham Facebook earnings estimates reduced at Needham on coronavirus impact 03/05/20 Snap upgraded to Buy from Neutral at MKM Partners 03/03/20 Jefferies Booking, Expedia, TripAdvisor price targets lowered at Jefferies

2020-03-17 07:58:39

Facebook

$145.83 / -24.83 (-14.55%)

07:58

03/17/20

03/17

07:58

03/17/20

07:58

Facebook added to Securities Investment Committee's Best Ideas List at Wedbush

Wedbush analyst Michael Pachter added the shares of Facebook to the Wedbush Securities Investment Committee's Best Ideas List. The analyst expects Facebook to continue its rapid growth overseas and to increase monetization of under-penetrated Instagram, WhatsApp, and Messenger. Pachter has an Outperform rating and a $250 price target on the shares.

17
Mar
17
Mar
25
Mar
20
Apr
14
Sep

FB Facebook

$145.83 / -24.83 (-14.55%)

03/11/20 Mizuho: Mizuho says own Internet stocks that benefit from travel restrictions

03/06/20 Needham: Facebook earnings estimates reduced at Needham on coronavirus impact

03/05/20: Snap upgraded to Buy from Neutral at MKM Partners

03/03/20 Jefferies: Booking, Expedia, TripAdvisor price targets lowered at Jefferies

TODAY'S FREE FLY STORIES

Downgrade	Lundin Energy downgraded to Sell from Hold at Societe Generale » 05:24 01/25/21 01/25 05:24 01/25/21 05:24 LNEGY Lundin Energy $0.00 / + (+0.00%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LNEGY Lundin Energy $0.00 / + (+0.00%) 01/07/21 DNB Markets Lundin Energy upgraded to Buy from Hold at DNB Markets 11/05/20 Kepler Cheuvreux Lundin Energy upgraded to Buy from Hold at Kepler Cheuvreux 10/19/20 Berenberg Lundin Energy price target lowered to SEK 270 from SEK 320 at Berenberg 10/19/20 Barclays Lundin Energy price target raised to SEK 265 from SEK 255 at Barclays
Upgrade	Fugro upgraded to Buy from Hold at ABN Amro » 05:23 01/25/21 01/25 05:23 01/25/21 05:23 FURGF Fugro $0.00 / + (+0.00%) ABN Amro analyst Thijs… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research FURGF Fugro $0.00 / + (+0.00%) 05:18 Today ING Bank Fugro upgraded to Buy from Hold at ING Bank 12/24/20 AlphaValue Fugro upgraded to Reduce from Sell at AlphaValue 07/17/20 Kepler Cheuvreux Fugro downgraded to Hold from Buy at Kepler Cheuvreux 05/29/20 ING Group Fugro downgraded to Hold from Buy at ING Bank
Downgrade	Serica Energy downgraded to Hold from Buy at Investec » 05:23 01/25/21 01/25 05:23 01/25/21 05:23 SQZZF Serica Energy $0.00 / + (+0.00%) Investec analyst Nathan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SQZZF Serica Energy $0.00 / + (+0.00%) 07/23/20 Investec Serica Energy initiated with a Hold at Investec 06/24/20 Jefferies Serica Energy downgraded to Hold from Buy at Jefferies 04/28/20 Jefferies Serica Energy price target raised to 115 GBp from 105 GBp at Jefferies
Hot Stocks	Philips, Rennes University Hospital announce five-year partnership » 05:22 01/25/21 01/25 05:22 01/25/21 05:22 PHG Philips $55.60 / +0.22 (+0.40%) Philips and Rennes… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PHG Philips $55.60 / +0.22 (+0.40%) 05:13 Today Philips, Vithas Group enter five-year innovation and collaboration agreement 01/19/21 Philips to acquire Capsule Technologies for $635M in cash, sees accretion 01/14/21 Philips. Merck partner on personalized fertility treatment solutions 01/11/21 Philips launches Philips Sonicare 9900 Prestige PHG Philips $55.60 / +0.22 (+0.40%) 01/20/21 Berenberg Philips price target raised to EUR 50 from EUR 49 at Berenberg 01/19/21 JPMorgan Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan 11/12/20 Berenberg Philips price target raised to EUR 49 from EUR 46 at Berenberg 10/29/20 Morgan Stanley Philips price target raised to EUR 50 from EUR 48 at Morgan Stanley PHG Philips $55.60 / +0.22 (+0.40%) 10/19/20 Philips reports Q3 adj. EPS EUR 0.60 vs. EUR 0.46 last year PHG Philips $55.60 / +0.22 (+0.40%) 01/05/21 Philips shortlists Asian suitors in home appliance unit sale, Bloomberg says PHG Philips $55.60 / +0.22 (+0.40%) 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers 09/05/20 Week in review: How Trump's policies moved stocks 03/02/21 2021 London Global Healthcare Virtual Conference 16:00 Today Philips - PHG
Upgrade	Beneteau upgraded to Buy from Hold at Kepler Cheuvreux » 05:22 01/25/21 01/25 05:22 01/25/21 05:22 BTEAF Beneteau $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BTEAF Beneteau $0.00 / + (+0.00%) 01/12/21 Oddo BHF Beneteau upgraded to Neutral from Reduce at Oddo BHF 12/11/20 Berenberg Beneteau initiated with a Buy at Berenberg 06/24/20 Exane BNP Paribas Beneteau downgraded to Neutral from Outperform at Exane BNP Paribas

Downgrade	Imerys downgraded to Hold from Buy at Kepler Cheuvreux » 05:21 01/25/21 01/25 05:21 01/25/21 05:21 IMYSF Imerys $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Upgrade	Halliburton upgraded to Overweight from Neutral at Atlantic Equities » 05:20 01/25/21 01/25 05:20 01/25/21 05:20 HAL Halliburton $19.24 / -0.18 (-0.93%) Atlantic Equities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options HAL Halliburton $19.24 / -0.18 (-0.93%) 01/19/21 Halliburton expects free cash flow to 'more than double' in 2021 01/19/21 Halliburton sees global supply, demand in balance in 2022 01/19/21 Halliburton says will 'continue to prioritize reducing leverage' 01/19/21 Halliburton says 'worst is behind us' HAL Halliburton $19.24 / -0.18 (-0.93%) 01/20/21 Fly Intel: Top five analyst upgrades 01/20/21 Northland Halliburton price target raised to $20 from $15 at Northland 01/20/21 Cowen Halliburton price target raised to $32 from $28 at Cowen 01/20/21 Susquehanna Halliburton bottom could be in after challenging year, says Susquehanna HAL Halliburton $19.24 / -0.18 (-0.93%) 01/19/21 Halliburton reports Q4 adjusted EPS 18c, consensus 15c 10/19/20 Halliburton reports Q3 adjusted EPS 11c, consensus 8c HAL Halliburton $19.24 / -0.18 (-0.93%) 11/11/20 OPEC+ discussing possible 3-to-6 month delay of production hikes, Bloomberg says 10/27/20 President Trump weighing executive order to show support for fracking, WSJ says HAL Halliburton $19.24 / -0.18 (-0.93%) 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/19/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Pre-market Movers 10/31/20 Week in review: How Trump's policies moved stocks 03/01/21 26th Annual Energy Virtual Summit HAL Halliburton $19.24 / -0.18 (-0.93%) 01/22/21 Halliburton call volume above normal and directionally bullish 12/11/20 Halliburton put volume heavy and directionally bearish 12/04/20 Halliburton call volume above normal and directionally bullish 11/16/20 Halliburton call volume above normal and directionally bullish
Downgrade	Basic-Fit downgraded to Hold from Buy at ING Bank » 05:19 01/25/21 01/25 05:19 01/25/21 05:19 BSFFF Basic-Fit $0.00 / + (+0.00%) ING Bank analyst Marc… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BSFFF Basic-Fit $0.00 / + (+0.00%) 06/30/20 Morgan Stanley Basic-Fit upgraded to Overweight from Equal Weight at Morgan Stanley 06/02/20 Barclays Basic-Fit price target raised to EUR 25 from EUR 20 at Barclays
Upgrade	Fugro upgraded to Buy from Hold at ING Bank » 05:18 01/25/21 01/25 05:18 01/25/21 05:18 FURGF Fugro $0.00 / + (+0.00%) ING Bank analyst Quirijn… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FURGF Fugro $0.00 / + (+0.00%) 12/24/20 AlphaValue Fugro upgraded to Reduce from Sell at AlphaValue 07/17/20 Kepler Cheuvreux Fugro downgraded to Hold from Buy at Kepler Cheuvreux 05/29/20 ING Group Fugro downgraded to Hold from Buy at ING Bank
Downgrade	Genmab downgraded to Sell from Hold at DNB Markets » 05:18 01/25/21 01/25 05:18 01/25/21 05:18 GMAB Genmab $43.05 / -0.08 (-0.19%) DNB Markets analyst Rune… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GMAB Genmab $43.05 / -0.08 (-0.19%) 01/15/21 Genmab says Janssen granted FDA approval for Darzalez Faspro 01/13/21 Genmab achieves $40M milestone in AbbVie collaboration 01/04/21 Genmab announces initiation of innovaTV 301 trial 11/24/20 Genmab will not advance development of enapotamab vedotin after POC data GMAB Genmab $43.05 / -0.08 (-0.19%) 01/19/21 Morgan Stanley Genmab downgraded to Equal Weight on valuation at Morgan Stanley 01/19/21 Morgan Stanley Genmab downgraded to Equal Weight from Overweight at Morgan Stanley 01/15/21 H.C. Wainwright Genmab price target raised to $49 from $44 at H.C. Wainwright 01/04/21 RBC Capital Genmab price target raised to $46 from $40 at RBC Capital

Upgrade	Novozymes upgraded to Overweight from Underweight at Barclays » 05:17 01/25/21 01/25 05:17 01/25/21 05:17 NVZMY Novozymes $0.00 / + (+0.00%) Barclays analyst Cezara… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NVZMY Novozymes $0.00 / + (+0.00%) 11/19/20 Barclays Novozymes price target raised to DKK 350 from DKK 340 at Barclays 11/18/20 Barclays Novozymes price target raised to DKK 350 from DKK 340 at Barclays 10/08/20 Berenberg Novozymes downgraded to Sell from Hold at Berenberg 10/01/20 Deutsche Bank Novozymes price target raised to DKK 360 from DKK 320 at Deutsche Bank
Hot Stocks	LexinFintech sees FY21 loan originations RMB 220B-RMB 230B » 05:16 01/25/21 01/25 05:16 01/25/21 05:16 LX LexinFintech $6.59 / -0.02 (-0.30%) LexinFintech announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Options LX LexinFintech $6.59 / -0.02 (-0.30%) 11/04/20 LexinFintech provides update on discussion draft regulatory development 09/14/20 LexinFintech announces management share purchase plan LX LexinFintech $6.59 / -0.02 (-0.30%) 06/16/20 China Renaissance China Renaissance ups LexinFintech to Buy, raises Fintech sector to Overweight 06/15/20 China Renaissance LexinFintech upgraded to Buy from Hold at China Renaissance 06/09/20 Citi LexinFintech upgraded to Buy following pullback at Citi 06/09/20 Citi LexinFintech upgraded to Buy from Neutral at Citi LX LexinFintech $6.59 / -0.02 (-0.30%) 08/18/20 LexinFintech reports Q2 EPS 30c, consensus 32c LX LexinFintech $6.59 / -0.02 (-0.30%) 08/25/20 LexinFintech a 'leverage time bomb,' short-seller Grizzly Research says LX LexinFintech $6.59 / -0.02 (-0.30%) 08/13/20 Largest borrow rate increases among liquid names
Upgrade	Leoni upgraded to Neutral from Underweight at JPMorgan » 05:15 01/25/21 01/25 05:15 01/25/21 05:15 LNNNY Leoni $0.00 / + (+0.00%) JPMorgan analyst Jose… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Upgrade	Outokumpu upgraded to Overweight from Underweight at JPMorgan » 05:13 01/25/21 01/25 05:13 01/25/21 05:13 OUTKY Outokumpu $0.00 / + (+0.00%) JPMorgan analyst Luke… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research OUTKY Outokumpu $0.00 / + (+0.00%) 01/19/21 Morgan Stanley Outokumpu price target raised to EUR 3.20 from EUR 2.70 at Morgan Stanley 01/18/21 Exane BNP Paribas Outokumpu downgraded to Neutral from Outperform at Exane BNP Paribas 12/16/20 SEB Equities Outokumpu upgraded to Buy from Hold at SEB Equities 12/10/20 Jefferies Outokumpu downgraded to Underperform from Hold at Jefferies
Hot Stocks	Philips, Vithas Group enter five-year innovation and collaboration agreement » 05:13 01/25/21 01/25 05:13 01/25/21 05:13 PHG Philips $55.60 / +0.22 (+0.40%) Philips and Vithas Group,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events PHG Philips $55.60 / +0.22 (+0.40%) 01/19/21 Philips to acquire Capsule Technologies for $635M in cash, sees accretion 01/14/21 Philips. Merck partner on personalized fertility treatment solutions 01/11/21 Philips launches Philips Sonicare 9900 Prestige 12/22/20 Philips, BioIntelliSense, University of Colorado receive DoD funding PHG Philips $55.60 / +0.22 (+0.40%) 01/20/21 Berenberg Philips price target raised to EUR 50 from EUR 49 at Berenberg 01/19/21 JPMorgan Philips price target raised to EUR 44 from EUR 39.40 at JPMorgan 11/12/20 Berenberg Philips price target raised to EUR 49 from EUR 46 at Berenberg 10/29/20 Morgan Stanley Philips price target raised to EUR 50 from EUR 48 at Morgan Stanley PHG Philips $55.60 / +0.22 (+0.40%) 10/19/20 Philips reports Q3 adj. EPS EUR 0.60 vs. EUR 0.46 last year PHG Philips $55.60 / +0.22 (+0.40%) 01/05/21 Philips shortlists Asian suitors in home appliance unit sale, Bloomberg says PHG Philips $55.60 / +0.22 (+0.40%) 12/18/20 Fly Intel: Wall Street's top stories for Friday 12/18/20 Fly Intel: Wall Street's top stories at midday 10/19/20 Fly Intel: Pre-market Movers 09/05/20 Week in review: How Trump's policies moved stocks 03/02/21 2021 London Global Healthcare Virtual Conference 16:00 Today Philips - PHG

Downgrade	Ocean Yield downgraded to Hold from Buy at Danske Bank » 05:11 01/25/21 01/25 05:11 01/25/21 05:11 OYIEF Ocean Yield $0.00 / + (+0.00%) Danske Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research OYIEF Ocean Yield $0.00 / + (+0.00%) 09/08/20 Danske Bank Ocean Yield upgraded to Buy from Hold at Danske Bank 05/13/20 Pareto Ocean Yield downgraded to Hold from Buy at Pareto 04/29/20 DNB Markets Ocean Yield upgraded to Buy from Hold at DNB Markets 03/09/20 DNB Markets Ocean Yield downgraded to Hold from Buy at DNB Markets
Upgrade	Topdanmark upgraded to Buy from Hold at Danske Bank » 05:10 01/25/21 01/25 05:10 01/25/21 05:10 TPDKY Topdanmark $0.00 / + (+0.00%) Danske Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TPDKY Topdanmark $0.00 / + (+0.00%) 01/14/21 SEB Equities Topdanmark upgraded to Buy from Hold at SEB Equities 11/25/20 Danske Bank Topdanmark downgraded to Hold from Buy at Danske Bank 11/24/20 Barclays Topdanmark price target raised to DKK 290 from DKK 287 at Barclays 10/27/20 Berenberg Topdanmark price target lowered to DKK 284 from DKK 290 at Berenberg
Upgrade	CD Projekt upgraded to Buy from Underperform at Jefferies » 05:10 01/25/21 01/25 05:10 01/25/21 05:10 OTGLY CD Projekt $0.00 / + (+0.00%) Jefferies analyst Ken… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly OTGLY CD Projekt $0.00 / + (+0.00%) 01/15/21 Activision's 'COD: Black Ops: Cold War' best-selling game of 2020, says NPD 12/22/20 CD Projekt reports 13M copies of 'Cyberpunk 2077' sold by December 20 12/18/20 Best Buy to allow returns of opened physical 'Cyberpunk 2077' units 12/18/20 Microsoft to offer full refunds to anyone who bought 'Cyberpunk' digitally OTGLY CD Projekt $0.00 / + (+0.00%) 01/12/21 Berenberg CD Projekt downgraded to Sell from Hold at Berenberg 12/18/20 Erste Group CD Projekt downgraded to Reduce from Buy at Erste Group 12/11/20 Barclays CD Projekt downgraded to Underweight from Equal Weight at Barclays 12/09/20 Jefferies CD Projekt downgraded to Underperform from Hold at Jefferies OTGLY CD Projekt $0.00 / + (+0.00%) 12/22/20 GameStop to accept returns of physical copies of 'Cyberpunk 2077,' Kotaku says 12/18/20 CD Projekt not in talks with Microsoft over 'Cyberpunk' removal, Reuters says 12/16/20 Sony won't refund certain orders of 'Cyberpunk 2077' on PS4, Kotaku says OTGLY CD Projekt $0.00 / + (+0.00%) 01/19/21 Game On: An exclusive talk with The Game Bakers' Emeric Thoa 12/22/20 Game On: Sony pulls buggy 'Cyberpunk 2077' from PS Store 12/15/20 Game On: NPD reports 35% year-over-year jump in November gaming spending 11/03/20 Game On: Activision, Ubisoft report earnings ahead of new console launches
Recommendations	Apple price target raised to $150 from $140 at Raymond James » 05:07 01/25/21 01/25 05:07 01/25/21 05:07 AAPL Apple $138.93 / +2.04 (+1.49%) Raymond James analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $138.93 / +2.04 (+1.49%) 01/21/21 VirnetX submits agreed BOC, prejudgement interest of $75.7M in Apple suit 01/19/21 Netflix says past year 'testament' to company's approach 01/17/21 Fly Intel: Top five weekend stock stories 01/15/21 VirnetX says court affirms jury award of $502.8M against Apple AAPL Apple $138.93 / +2.04 (+1.49%) 01/22/21 Cowen Apple price target raised to $153 from $133 at Cowen 01/21/21 DA Davidson Apple's well positioned with first lineup of 5G phones, says DA Davidson 01/21/21 Evercore ISI Facebook price target raised to $355 from $320 at Evercore ISI 01/21/21 Cowen Apple EV opportunity may be in partnership, says Cowen AAPL Apple $138.93 / +2.04 (+1.49%) 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year 10/29/20 Apple reports Q4 iPhone revenue $24.44B vs. $33.36B last year 10/29/20 Apple reports Q4 EPS 73c, consensus 70c AAPL Apple $138.93 / +2.04 (+1.49%) 01/23/21 Big tech stocks are back, Barron's says 01/22/21 Foxconn said to receive extra iPhone 12 Pro orders, DigiTimes reports 01/21/21 Apple's first headset to focus on virtual reality, Bloomberg reports 01/17/21 Apple considering foldable iPhone, minor changes for 2021 models, Bloomberg says AAPL Apple $138.93 / +2.04 (+1.49%) 01/20/21 #SocialStocks: Facebook could be in focus under new administration 01/20/21 Street Fight: Analysts diverge on Lumentum after Coherent deal announcement 01/19/21 Lumentum slides after announcing $5.7B merger deal with Coherent 01/19/21 Facebook upgrade, Roku initiation among today's top calls on Wall Street 01/27/21 Apple - AAPL 02/23/21 Apple, Inc. AAPL Apple $138.93 / +2.04 (+1.49%) 01/22/21 Notable open interest changes for January 22nd 01/21/21 Notable open interest changes for January 21st 01/21/21 Apple call buyer realizes 39% same-day gains 01/20/21 Notable open interest changes for January 20th
Hot Stocks	uCloudlink, Vision expand mobile data connectivity partnership » 05:07 01/25/21 01/25 05:07 01/25/21 05:07 UCL uCloudlink $10.36 / +0.11 (+1.07%) uCloudlink and Vision… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Syndicate UCL uCloudlink $10.36 / +0.11 (+1.07%) 01/19/21 uCloudlink enters strategic agreement with CVITC for smart container solutions 01/13/21 uCloudlink announces progress in U.S., China patent infringement disputes 01/04/21 uCloudlink, China Mobile continue mobile connectivity partnership 12/21/20 uCloudlink extends data procurement partnership with Vodafone 10 Jun

Upgrade	Dai-ichi Life upgraded to Conviction Buy from Buy at Goldman Sachs » 05:03 01/25/21 01/25 05:03 01/25/21 05:03 DCNSF Dai-ichi Life $0.00 / + (+0.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DCNSF Dai-ichi Life $0.00 / + (+0.00%) 07/01/20 Goldman Sachs Dai-ichi Life upgraded to Buy from Neutral at Goldman Sachs 06/17/20 Daiwa Dai-ichi Life upgraded to Buy from Neutral at Daiwa
Recommendations	Novocure price target raised to $225 from $140 at Piper Sandler » 05:01 01/25/21 01/25 05:01 01/25/21 05:01 NVCR Novocure $168.99 / -2.74 (-1.60%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NVCR Novocure $168.99 / -2.74 (-1.60%) 12/14/20 Novocure announces BAG to add Optune combination to MiGeL 12/10/20 Novocure enrolls 1st patient in global phase 3 TRIDENT trial 11/11/20 Novocure receives CE Mark for NovoTTF-100L system 10/29/20 Novocure forms alliance with NYU Grossman School of Medicine NVCR Novocure $168.99 / -2.74 (-1.60%) 01/12/21 Wedbush Novocure price target raised to $159 from $110 at Wedbush 10/30/20 Mizuho Novocure price target raised to $150 from $84 at Mizuho 10/29/20 Piper Sandler Novocure price target raised to $140 from $125 at Piper Sandler 10/05/20 Piper Sandler Bristol-Myers approval removes some Novocure revenue upside, says Piper Sandler NVCR Novocure $168.99 / -2.74 (-1.60%) 01/11/21 Novocure sees FY20 revenue $494.4M, consensus $482.29M 01/11/21 Novocure sees Q4 revenue $144M, consensus $133.26M 10/29/20 Novocure reports Q3 EPS 9c, consensus 3c 07/30/20 Novocure reports Q2 EPS 2c, consensus 0c 02/25/21 Novocure - NVCR
Initiation	Cushman & Wakefield initiated with a Neutral at Goldman Sachs » 04:59 01/25/21 01/25 04:59 01/25/21 04:59 CWK Cushman & Wakefield $15.19 / +0.28 (+1.88%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly CWK Cushman & Wakefield $15.19 / +0.28 (+1.88%) 01/05/21 Cushman & Wakefield names Neil Johnston as CFO 12/14/20 Cushman & Wakefield appoints Nadine Augusta as CDEIO 09/01/20 Cushman & Wakefield arranges $80M sale of Colton Creek apartment community 08/31/20 Carrier Global, Cushman & Wakefield to collaborate to enhance health, safety CWK Cushman & Wakefield $15.19 / +0.28 (+1.88%) 12/21/20 JPMorgan Cushman & Wakefield price target raised to $17 from $13 at JPMorgan 09/17/20 Fly Intel: Top five analyst initiations 09/17/20 Raymond James Cushman & Wakefield initiated with an Outperform at Raymond James 09/16/20 Raymond James Cushman & Wakefield initiated with an Outperform at Raymond James CWK Cushman & Wakefield $15.19 / +0.28 (+1.88%) 11/05/20 Cushman & Wakefield reports Q3 adjusted EPS 16c, consensus 17c 08/06/20 Cushman & Wakefield reports Q2 adjusted EPS 19, consensus 8c CWK Cushman & Wakefield $15.19 / +0.28 (+1.88%) 10/19/20 W. R. Berkley begins sale of $1.1B London headquarters, Bloomberg reports CWK Cushman & Wakefield $15.19 / +0.28 (+1.88%) 08/04/20 Fly Intel: Wall Street's top stories for Tuesday 08/04/20 Fly Intel: Wall Street's top stories at midday
Initiation	Colliers International initiated with a Neutral at Goldman Sachs » 04:58 01/25/21 01/25 04:58 01/25/21 04:58 CIGI Colliers International $93.44 / +0.635 (+0.68%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CIGI Colliers International $93.44 / +0.635 (+0.68%) 12/01/20 Colliers International promotes Rebecca Finley to chief brand, people officer 09/02/20 Colliers International acquires Colliers International Nashville 09/01/20 Colliers International to establish company-owned office in North Carolina CIGI Colliers International $93.44 / +0.635 (+0.68%) 10/28/20 Raymond James Colliers International price target raised to $90 from $75 at Raymond James 03/10/20 RBC Capital RBC backs Outperform on Colliers amid economic uncertainty 02/14/20 RBC Capital Colliers International price target raised to $94 from $80 at RBC Capital CIGI Colliers International $93.44 / +0.635 (+0.68%) 10/27/20 Colliers International reports Q3 adj. EPS $1.08, consensus 79cc 08/06/20 Colliers International reports Q2 adj. EPS 70c, consensus 42c 02/11/21 Colliers International - CIGI
Initiation	Newmark initiated with a Buy at Goldman Sachs » 04:57 01/25/21 01/25 04:57 01/25/21 04:57 NMRK Newmark $7.33 / +0.115 (+1.60%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NMRK Newmark $7.33 / +0.115 (+1.60%) 10/19/20 Newmark Group announces formal rebranding to Newmark NMRK Newmark $7.33 / +0.115 (+1.60%) 12/23/20 Piper Sandler Newmark price target raised to $7.50 from $5 at Piper Sandler 04/09/20 BofA Newmark double-downgraded to Underperform from Buy at BofA 04/09/20 BofA Newmark downgraded to Underperform from Buy at BofA 02/14/20 Wedbush Newmark downgraded to Neutral from Outperform at Wedbush NMRK Newmark $7.33 / +0.115 (+1.60%) 11/05/20 Newmark reports Q3 adjusted EPS 44c, consensus 42c 08/06/20 Newmark not providing 2020 guidance 08/06/20 Newmark reports Q2 adjusted EPS 10c, consensus 19c 02/18/21 Newmark - NMRK

Events

Earnings calls, analyst events, roadshows and more

Today at 08:30

Chicago Fed National Activity Index--3 Month Moving Average: December 2020 Government Event
Today at 08:30

Chicago Fed National Activity Index: December 2020 Government Event
CADE
Today at 08:30

Cadence Bancorp - CADE Conference Calls
SMG
Today at 09:00

The Scotts Miracle-Gro Company Firm Sponsored Meetings
OFG
Today at 10:00

OFG Bancorp - OFG Conference Calls
KMB
Today at 10:00

Kimberly-Clark - KMB Conference Calls
Today at 10:30

Dallas Fed Manufacturing Survey--General Activity Index: January 2021 Government Event
Today at 10:30

Dallas Fed Manufacturing Survey Production Index: January 2021 Government Event
CBU
Today at 11:00

Community Bank System - CBU Conference Calls
FRBK
Today at 11:00

Republic First Bancorp - FRBK Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 2.8M Shares
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $19.00-21.00 50M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $22.00-26.00 49.2M Shares ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares
Thurs	SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares
Fri	No deals

View All Syndicate Announcements »

Facebook added to Securities Investment Committee's Best Ideas List at Wedbush

TODAY'S FREE FLY STORIES

Get Full Fly Access